Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
ACURA PHARMA Add to My Watchlist (NSDQ: ACUR) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     ACURA 4.51 -0.05 (-1.10%) 1,100
616 N.North Court
Suite 120
Palatine, IL 60067 US
(847) 705-7709
(847) 705-5399 fax
www.acurapharm.com
CEO Andrew D. Reddick
Auditor BDO Seidman, LLP
Exchange Traded NQ
ISIN Number US00509L7038
CIK Number 786947
NAICS Code 325412
Business Summary
A specialty pharmaceutical company, which is engaged in the research, development and manufacture of product candidates providing abuse deterrent features and benefits.
Number of Employees 15
Share Fundamentals
Market Cap 193.79M
Shares Outstanding 42.97M
Float 42.94M
Short Interest 817.61K
Financial Strength
Revenue (TTM) $10,873,000
Earnings (TTM) -$14,744,000
Quick Ratio 11.6:1
Current Ratio 11.7:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin -78.0%
Profit Margin -77.1%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs